Collectively, these results suggest that RBFOX2 is required for AML cell survival and leukaemia maintenance, which it may facilitate by promoting LSC/LIC self-renewal and inhibiting AML cell differentiation. The gene discussed is RBFOX2; the disease is acute myeloid leukemia.